Interestingly, α 2-6 sialyltransferase I (ST6GalNAc-I) was associated with better prognosis in breast cancer in a study that compared mRNA levels of ST6GalNAc-I genes in 127 breast cancer tissues to 33 normal background tissues[22]. This evidence concerns the gene ST6GALNAC1 and breast carcinoma.